Rockefeller Capital Management L.P.
Position in MBRX — Moleculin Biotech, Inc.
CIK 1739439
NEW YORK, NY
Position in MBRX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$10,124
+$9,403 QoQ
Shares Held
4,421
+1928.0% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 20 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rockefeller Capital Management L.P. holds $285,800,136 across 243 Biotechnology names. MBRX ranks #163 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
149,655 | $66,826,941 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
249,174 | $47,106,343 | |
| 3 | PTCT |
Ptc Therapeutics, Inc.
|
384,672 | $26,207,702 | |
| 4 | ACAD |
Acadia Pharmaceuticals Inc
|
1,027,357 | $22,868,965 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
28,520 | $22,035,691 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
372,197 | $21,025,406 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
33,849 | $17,718,934 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
123,497 | $4,978,162 |
All Filings in MBRX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,124 | 4,421 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $721 | 218 | Shares | Defined | 2026-03-17 | |
| No filing history on record for this holder in this stock. | ||||||